SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10794	Companies
233195	Keywords
161787	Articles
124392	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 09/20/2024 at 11:30, 1 year 10 months ago

Press Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study
Study shows tolebrutinib delays disability progression in non-relapsing secondary progressive MS by 31%; global regulatory submissions in H2 2024. ECTRIMS 2024 data presented

ECTRIMS 2024 Tolebrutinib Disability Progression Secondary Progressive MS Global Regulatory Submissions
BRIEF

published on 09/16/2024 at 18:49, 1 year 10 months ago

Sanofi Reports Share and Voting Rights Data for August 2024

Voting Rights Shares Investor Relations Sanofi August 2024
PRESS RELEASE

published on 09/16/2024 at 18:44, 1 year 10 months ago

Sanofi: Information concerning the total number of voting rights and shares - August 2024
Sanofi discloses total number of voting rights and shares as per French Commercial Code and AMF regulations

Voting Rights French Commercial Code Shares AMF Regulations Sanofi
BRIEF

published on 09/11/2024 at 07:10, 1 year 10 months ago

Dupixent Phase 3 Study Shows Promise for CSU Patients

Sanofi Phase 3 Dupixent CSU Regeneron
PRESS RELEASE

published on 09/11/2024 at 07:05, 1 year 10 months ago

Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU
Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU. Positive pivotal data support Dupixent as a new targeted therapy for CSU

Phase 3 Study Dupixent CSU Chronic Spontaneous Urticaria Itch And Hives
BRIEF

published on 09/11/2024 at 07:05, 1 year 10 months ago

Dupixent Demonstrates Significant Efficacy in Bullous Pemphigoid

Clinical Trial Sanofi Dupixent Bullous Pemphigoid Disease Remission
PRESS RELEASE

published on 09/11/2024 at 07:00, 1 year 10 months ago

Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
Dupixent achieves significant improvements in disease remission and symptoms in bullous pemphigoid study. Study met primary and key secondary endpoints with beneficial steroid-sparing effect

Dupixent Bullous Pemphigoid Disease Remission Symptoms Steroid-sparing Effect
BRIEF

published on 08/09/2024 at 21:16, 1 year 11 months ago

Sanofi publishes its capital and voting rights figures for July 2024

Share Capital Voting Rights Financial Markets Authority July 2024 Sanofi Actions
PRESS RELEASE

published on 08/09/2024 at 21:11, 1 year 11 months ago

Sanofi: Information concerning the total number of voting rights and shares - July 2024
Sanofi discloses total voting rights and shares as per French Commercial Code and AMF Regulations for July 31, 2024

French Commercial Code Total Voting Rights AMF Regulations Sanofi July 31 2024
BRIEF

published on 08/08/2024 at 07:05, 1 year 11 months ago

Sarclisa Improves Progression-Free Survival for Multiple Myeloma Patients Eligible for Transplant

Clinical Study Sanofi Multiple Myeloma Sarclisa Progression-free Survival

Accesswire

Published on 08/01/2026 at 01:20, 2 days 5 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 5 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 6 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 2 days 6 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 2 days 7 hours ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 06:45, 11 minutes ago

HDBank secures record international syndicated social loan in Vietnam
Published on 08/03/2026 at 06:30, 26 minutes ago

HDBank posts 31% rise in first-half profit, assets exceed VND1 quadrillion
Published on 08/03/2026 at 04:05, 2 hours 51 minutes ago

UD info Launches One-Stop Industrial-Grade SD and microSD Card Solutions
Published on 08/03/2026 at 03:30, 3 hours 26 minutes ago

Coway Releases 21st Sustainability Report for FY2025
Published on 08/03/2026 at 00:05, 6 hours 52 minutes ago

Publication of the result of the voluntary public tender offer for all Addiko shares

Les Echos

Published on 07/31/2026 at 21:00, 2 days 9 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 11 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 2 days 11 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 2 days 11 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 2 days 12 hours ago

Covivio Hotels - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE